1,160
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Biochemical and histopathological evidence on the beneficial effects of Tragopogon graminifolius in TNBS-induced colitis

, , , , , , & show all
Pages 429-436 | Received 21 Dec 2013, Accepted 07 May 2014, Published online: 04 Dec 2014

Figures & data

Table 1. Criteria for scoring macroscopic and microscopic colonic damage.

Figure 1. Histological images of colon tissues obtained from control and experimental groups. Microscopic evaluation of the control group showed intense transmural inflammation and/or diffuse necrosis (A) and severe crypt destruction (B). In histological examination of the dexamethasone group, minimal mucosal inflammation was observed (C). In the TG-20 group, almost complete necrosis of crypts (D) and severe inflammation of mucosa and submucosa were observed (E). In the TG-30 group, diffuse destruction of crypts was observed (F). In the TG-50 group, no necrosis in crypt (G) and mild inflammation of mucosa (H) were observed.

Figure 1. Histological images of colon tissues obtained from control and experimental groups. Microscopic evaluation of the control group showed intense transmural inflammation and/or diffuse necrosis (A) and severe crypt destruction (B). In histological examination of the dexamethasone group, minimal mucosal inflammation was observed (C). In the TG-20 group, almost complete necrosis of crypts (D) and severe inflammation of mucosa and submucosa were observed (E). In the TG-30 group, diffuse destruction of crypts was observed (F). In the TG-50 group, no necrosis in crypt (G) and mild inflammation of mucosa (H) were observed.

Table 2. Macroscopic and microscopic scores as criteria for assessing colonic damage.

Figure 2. Tumor necrosis factor-alpha (TNF-α) level in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aaSignificantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 2. Tumor necrosis factor-alpha (TNF-α) level in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aaSignificantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 3. Interleukin 1-beta (IL-1β) level in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aaSignificantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 3. Interleukin 1-beta (IL-1β) level in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aaSignificantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 4. Total antioxidant power as ferric-reducing antioxidant power (FRAP) level in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aaSignificantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 4. Total antioxidant power as ferric-reducing antioxidant power (FRAP) level in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aaSignificantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 5. Lipid peroxidation (LPO) levels as thiobarbituric acid reacting substances (TBARS) in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aaSignificantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 5. Lipid peroxidation (LPO) levels as thiobarbituric acid reacting substances (TBARS) in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aaSignificantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 6. Myeloperoxidase activity (MPO) in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aa Significantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 6. Myeloperoxidase activity (MPO) in colon. Values are mean ± SEM. Dexa, dexamethasone; TG20, T. graminifolius at dose of 20 mg/kg; TG30, T. graminifolius at dose of 30 mg/kg; TG50, T. graminifolius at dose of 50 mg/kg. aSignificantly different from the Normal group at p < 0.05. bSignificantly different from the control group at p < 0.05. cSignificantly different from the Dexa group at p < 0.05. aa Significantly different from the Normal group at p < 0.01. bbSignificantly different from the control group at p < 0.01. ccSignificantly different from the Dexa group at p < 0.01. aaaSignificantly different from the Normal group at p < 0.001. bbbSignificantly different from the control group at p < 0.001. cccSignificantly different from the Dexa group at p < 0.001.

Figure 7. Chemical structures of the phenolic compounds that are quantified by HPLC for standardization of the extract from T. graminifolius.

Figure 7. Chemical structures of the phenolic compounds that are quantified by HPLC for standardization of the extract from T. graminifolius.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.